We are pleased to welcome Dr Claire Ellis at the next EEG Working Group meeting.

In this talk, Claire will present her current work, which explores how low-dose psilocybin modulates EEG complexity measures, with the aim of understanding potential differential effects on brain dynamics in autistic and non-autistic adults. Findings may have implications for both the neurobiology of autism and the therapeutic potential of psychedelics.

Join us for a discussion about the role of EEG in neurodiversity research, and what psychedelics might reveal about brain function across different populations.

About the speaker

Dr Claire Ellis is a postdoctoral research associate at the Department of Forensic and Neurodevelopmental Sciences at the Institute of Psychiatry, Psychology & Neuroscience, King’s College London.

Claire’s previous work has focused on identifying EEG-based markers of excitatory-inhibitory (E-I) balance and evaluating their validity using neurochemical (1H-Magnetic Resonance Spectroscopy) and pharmacological (GABAB agonist) approaches. Her research has provided evidence that the aperiodic 1/f exponent can be used as a non-invasive proxy for dynamic E-I signalling, with relevance to understanding dynamic differences in autism.

Date and time 

Friday, 25 April 2025, 11:00 - 12:00

Location

This meeting is online only.

• Online: on Microsoft Teams.

To receive the meeting link, join our Teams channel (using this link or the Teams code: a2qd0zr) or contact one of our group leads, Dr Irene Faiman at: irene.faiman@kcl.ac.uk, or Dr Andrea Biondi at: andrea.2.biondi@kcl.ac.uk.